Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial

Update Il y a 4 ans
Reference: NCT00407797

Woman and Man

  • | Country :
  • Mexico
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to assess the clinical improvement by partial seizures reduction, safety and tolerability of subjects having partial epilepsy related to the adjunction of pregabalin BID (75 to 300mg day titration, BID) to existing standard AED (Antiepileptic drugs).


Inclusion criteria

  • Partial seizures

Links